The global 3D bio-printed human tissue market is projected to record a CAGR of 8.3% during the forecast period. The current valuation of the market is US$ 2.13 Billion in 2022. The market value of the 3D bio-printed human tissue market is anticipated to reach a high of US$ 11.66 Billion by the year 2032. A historical market valuation of US$ 1.8 Billion has been recorded in the analysis conducted by Future Market Insights.
| Report Attribute | Details |
|---|---|
| Market Value (2022) | US$ 2.13 Billion |
| Market Anticipated Value (2032) | US$ 11.66 Billion |
| Market Projected Growth Rate (2022 to 2032) | 8.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
It is identified that the market for 3D bio-printed human tissue is witnessing an unprecedented surge in recent years. There has been an approximate surge of 1.5 Billion from the base year to the current. A robust demand for 3D bio-printing across diverse industries include healthcare, pharmaceutical, and biotech markets. This aspect is a key demand driver accelerating the growth of the market in 2023.
In addition to that, the major technological developments in the field of 3D bioprinting such as the treatment of cancer, modeling of liver, tissue and bones production, and epidermal layer growth is projected to make a significant contribution to the market through the forecast period.
3D bio-printers are highly getting employed in beauty treatments which is another key reason estimated to boost the growth of the market through the estimated timeframe. The same is also being used for drug screening and clinical studies. Public and private financing, coupled with research initiatives are also expected to revamp the market landscape through the projection period.
Although the market is having healthy growth, it is estimated that a certain number of elements prevailing in the market are likely to deter the growth of the industry in the long run. Due to the advanced technology, a lack of skilled labor across the developing economies is likely to pose a threat to market expansion.
Additionally, significant development and production expenses also act as a key deterring element in the foreseen years.
Principal Consultant
The manufacturers in the 3D bio-printed human tissue market are leveraging advancements in technology to launch new products and gain a competitive advantage. These firms are continually investing in research and development activities to keep themselves in tandem with the changing consumer preferences and end-use industry demands. Efforts are being made to comply with the safety regulations in the market and aid the further progression of the market. Thus, the market is likely to witness significant growth through 2032. Additive manufacturing i.e. 3D printing is either already used or being seriously considered in the aerospace & defence industry, automobile manufacturing, textile production, medical healthcare devices and computer equipment.
It was first used for creating rapid prototypes and was conceived in the 1980’s. Rapid advances in the field have led us to the advent of bioprinting in the 21st century. 3D bioprinting, as the name suggests, is a technique of recreating cells in a confined space with the help of 3D printers.
Cell function and viability are preserved through this process which enables its use in either organ replacement or tissue engineering. The 3D bioprinted human tissue market is mainly concerned with the latter. While it has much in common with traditional additive manufacturing, the 3D bioprinted human tissue market has a number of unique characteristics and challenges exclusive to it.
The main driver for the 3D bioprinted human tissue market is expected to be the field of tissue engineering. Tissue engineering is meant to repair or even replace different tissues like bone, blood vessel, cartilage, bladder, muscle, skin, heart etc.
Demand for tissue engineering is expected to surge following the shift in focus from stem cell therapy to immune cellular therapies. A second important driver could be the organ replacement market. Medical institutions across the world are facing a severe shortage of organs that can be donated.
3D bioprinting could be used to replace parts of or even the entire tissue, saving countless lives in the process. It would also have the advantage of the transplanted organ being readily accepted, since the patient’s body would not treat the donor’s organ as ‘foreign’.
The 3D bioprinted human tissue market could also be relevant in the booming global cosmetic surgery speciality. Patients could download a face scan from the Internet and apply it on their own. People might also want to have their face scanned during their teenage years, and reapply it every few years to appear as a perpetual youth!
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
While bioprinting is evolving very rapidly, there are still some major challenges which constrain the 3D bioprinted human tissues market, one of which is cell vascularization. 3D bioprinted human tissues would not get enough nutrients, be able to exchange gases or dispose of waste properly without a sound vascular network.
This is an issue not only for 3D bioprinted human tissue but also for the 3D printed organ market. An effect of this is low cell viability, which means the tissue cannot be used for anything barring research purposes. Another restraint is the rapid tissue maturation process, where printed organs must be quickly fused, remodelled and matured towards a solid construct.
The third critical challenge is the lack of biomaterials available. Bioprinting can only use a handful of materials at present and not all integrate seamlessly with the printing hardware along with possessing all the desired biological properties. These are the main reasons why the 3D bioprinted human tissue market has not been able to achieve its full potential yet.
North America is the largest 3D bioprinted human tissue market at present and is expected to remain so for the foreseeable future. This is due to the major 3D bioprinting players being based here, strong government investment in healthcare, massive R&D spending as well as a thriving private sector.
The APAC region is anticipated to become increasingly important in the long term due to strong fundamentals. Europe will remain stable and is not expected to post very high growth rates in the 3D bioprinted human tissue market.
Key 3D bioprinted human tissue market players include Organovo, Stratasys Ltd., 3D Systems, Inc., SOLS Systems, Youbionic, Materialise NV, Oceanz 3D printing, The Pexion Group, &, and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Explore Healthcare Insights
View Reports
3D Bioprinted Human Tissue Market
